25 May 2013
Keywords: bayer, offer, schering, ag, unchanged, despite, ultravist
Article | 07 August 2006
Following the announcement by Schering AG that it is voluntarily withdrawing its X-ray contrast media agent Ultravist injection 370mgl/ml
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 August 2006
7 August 2006
24 May 2013
© 2013 thepharmaletter.com